Is a complete FTH research report available?

No complete published report is available for Faeth Therapeutics, Inc. (FTH) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Faeth Therapeutics, Inc. (FTH)

NASDAQ: FTH · USD

$19.3

+0.16 (+0.8%)· Recorded snapshot

Market cap	497.9M
Net income (ttm)	-195.5M
EPS (ttm)	-$82.5
Shares out	25.8M
Volume	377,975
Beta	-0.29

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -195.5M
EPS (ttm): -$82.5
Market cap: 497.9M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

Metric	Value
Amount currency	USD
CIK code	0001829802
Company name	Faeth Therapeutics, Inc.
Country	United States
Country code	US
CUSIP number	81728A207
Earnings date	2026-11-13
Earnings time	bmo
Employees	29
Employees change	14
Employees growth	93.33%
Enterprise value	$312.1M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-07-12
Fiscal year end	December
Founded	1999
Industry	Biotechnology
IPO date	2021-02-04
Is primary listing	Yes
Is SPAC	No
ISIN number	US81728A2078
Last 10-K release date	2026-03-30
Last earnings date	2026-08-04
Last refreshed	2026-10-28
Last stock split date	2025-06-17
Last stock split type	Reverse
Market cap	$497.9M
Market cap category	Small-Cap
Next earnings date	2026-11-13
Options	No
Price	$19.27
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	FTH
U.S. state	Maryland
Website	https://www.faeththerapeutics.com

Metric

Value

Amount currency

USD

CIK code

0001829802

Company name

Faeth Therapeutics, Inc.

Country

United States

Country code

CUSIP number

81728A207

Earnings date

2026-11-13

Earnings time

bmo

Employees

Employees change

Employees growth

93.33%

Enterprise value

$312.1M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-07-12

Fiscal year end

December

Founded

1999

Industry

Biotechnology

IPO date

2021-02-04

Is primary listing

Yes

Is SPAC

ISIN number

US81728A2078

Last 10-K release date

2026-03-30

Last earnings date

2026-08-04

Last refreshed

2026-10-28

Last stock split date

2025-06-17

Last stock split type

Reverse

Market cap

$497.9M

Market cap category

Small-Cap

Next earnings date

2026-11-13

Options

Price

$19.27

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

FTH

U.S. state

Maryland

Website

https://www.faeththerapeutics.com

Metric	Value
Earnings yield	-427.91%
FCF / EV yield	-10.03%
FCF yield	-6.47%
P/B ratio	2.85x
Price / tangible book value	3.03x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-427.91%

FCF / EV yield

-10.03%

FCF yield

-6.47%

P/B ratio

2.85x

Price / tangible book value

3.03x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Profit per employee	$-6.7M
ROA	-20.79%
ROA (5Y)	-29.57%
ROCE	-20.46%
ROE	-195.26%
ROE (5Y)	-51.43%
ROIC	-22.59%

Metric

Value

Profit per employee

$-6.7M

ROA

-20.79%

ROA (5Y)

-29.57%

ROCE

-20.46%

ROE

-195.26%

ROE (5Y)

-51.43%

ROIC

-22.59%

Metric	Value
EPS growth quarters	1
EPS growth years	3
Net income growth years	3
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth years

Revenue growth years

Metric	Value
Capital expenditures	$-6,000
Depreciation and amortization	$123,000
EBIT	$-36.8M
EBITDA	$-36.6M
EPS	$-82.46
FCF per share	$-1.31
Financing cash flow	$183.9M
Free cash flow	$-33.9M
Free cash flow minus SBC	$-51.8M
Investing cash flow	$-135.7M
Net borrowing	$-345,000
Net cash flow	$14.3M
Net income	$-195.5M
Operating cash flow minus SBC	$-51.8M
Operating income	$-36.8M
Stock-based compensation	$17.9M

Metric

Value

Capital expenditures

$-6,000

Depreciation and amortization

$123,000

EBIT

$-36.8M

EBITDA

$-36.6M

EPS

$-82.46

FCF per share

$-1.31

Financing cash flow

$183.9M

Free cash flow

$-33.9M

Free cash flow minus SBC

$-51.8M

Investing cash flow

$-135.7M

Net borrowing

$-345,000

Net cash flow

$14.3M

Net income

$-195.5M

Operating cash flow minus SBC

$-51.8M

Operating income

$-36.8M

Stock-based compensation

$17.9M

Metric	Value
Book value per share	$6.70
Debt / equity	0
Interest coverage	-1,148.84
Long-term assets	$648,000
Long-term liabilities	$6.8M
Net cash (debt)	$185.8M
Net cash / market cap	35.5%
Net cash growth	612.91%
Net debt / equity	-1.07
Piotroski F-Score	2
Property, plant and equipment	$568,000
Shareholders' equity	$173M
Tangible book value	$173M
Tangible book value per share	$6.70
Total assets	$189.3M
Total cash	$186.4M
Total debt	$592,000
Total liabilities	$16.3M
WACC	2.67%

Metric

Value

Book value per share

$6.70

Debt / equity

Interest coverage

-1,148.84

Long-term assets

$648,000

Long-term liabilities

$6.8M

Net cash (debt)

$185.8M

Net cash / market cap

35.5%

Net cash growth

612.91%

Net debt / equity

-1.07

Piotroski F-Score

Property, plant and equipment

$568,000

Shareholders' equity

$173M

Tangible book value

$173M

Tangible book value per share

$6.70

Total assets

$189.3M

Total cash

$186.4M

Total debt

$592,000

Total liabilities

$16.3M

WACC

2.67%

Metric	Value
Current assets	$188.7M
Current liabilities	$9.6M
Current ratio	19.69
Net working capital	$-6.8M
Quick ratio	19.46
Working capital	$179.1M

Metric

Value

Current assets

$188.7M

Current liabilities

$9.6M

Current ratio

19.69

Net working capital

$-6.8M

Quick ratio

19.46

Working capital

$179.1M

Metric	Value
Buyback yield / dilution	-88.34%
Dividend yield	0%
Shareholder yield	-88.34%

Metric

Value

Buyback yield / dilution

-88.34%

Dividend yield

Shareholder yield

-88.34%

Metric	Value
150-day SMA	$26.55
1D price change	0.84%
1M price change	-31.36%
1M total return	-31.36%
1W price change	-7.55%
1W total return	-7.55%
1Y price change	89.92%
1Y return CAGR	90%
1Y total return	89.92%
20-day SMA	$22.22
200-day SMA	$25.07
3M price change	-34.27%
3M total return	-34.27%
3Y price change	71.61%
3Y return CAGR	19.72%
3Y total return	71.61%
50-day SMA	$29.36
50-day SMA vs 200-day SMA	50over200
52-week high	$42.14
52-week high date	2026-09-08
52-week low	$7.45
52-week low date	2025-12-05
5Y price change	-88.95%
5Y return CAGR	-35.64%
5Y total return	-88.95%
6M price change	-39.06%
6M total return	-39.06%
All-time high	$530.00
All-time high date	2021-02-04
All-time low	$5.00
All-time low date	2025-03-31
Average true range (ATR)	$2.48
Average volume	364.4K
Beta (1Y)	3.02
Beta (2Y)	2.24
Beta (5Y)	-0.29
Change from 52-week high	-54.27%
Change from 52-week low	158.66%
Change from all-time high	-96.37%
Change from all-time low	284.4%
Change from open	0.47%
Day's gap	0.37%
Dollar volume	$7.3M
High price	$20.55
Low price	$19.18
Monthly RSI	45.28
Open price	$19.18
Position in 52-week range	6.57%
Previous close	$19.11
Price vs 150-day SMA	-27.61%
Price vs 20-day SMA	-13.51%
Price vs 200-day SMA	-23.34%
Price vs 50-day SMA	-34.53%
Relative volume	1.04
Return from IPO open	-95.9%
RSI	36.03
Sharpe ratio	0.94
Sharpe ratio (3Y)	0.65
Sharpe ratio (5Y)	0.18
Sortino ratio	2.93
Sortino ratio (3Y)	1.51
Sortino ratio (5Y)	0.44
Volume	378K
Weekly RSI	43.56
YTD price change	80.13%
YTD total return	80.13%

Metric

Value

150-day SMA

$26.55

1D price change

0.84%

1M price change

-31.36%

1M total return

-31.36%

1W price change

-7.55%

1W total return

-7.55%

1Y price change

89.92%

1Y return CAGR

90%

1Y total return

89.92%

20-day SMA

$22.22

200-day SMA

$25.07

3M price change

-34.27%

3M total return

-34.27%

3Y price change

71.61%

3Y return CAGR

19.72%

3Y total return

71.61%

50-day SMA

$29.36

50-day SMA vs 200-day SMA

50over200

52-week high

$42.14

52-week high date

2026-09-08

52-week low

$7.45

52-week low date

2025-12-05

5Y price change

-88.95%

5Y return CAGR

-35.64%

5Y total return

-88.95%

6M price change

-39.06%

6M total return

-39.06%

All-time high

$530.00

All-time high date

2021-02-04

All-time low

$5.00

All-time low date

2025-03-31

Average true range (ATR)

$2.48

Average volume

364.4K

Beta (1Y)

3.02

Beta (2Y)

2.24

Beta (5Y)

-0.29

Change from 52-week high

-54.27%

Change from 52-week low

158.66%

Change from all-time high

-96.37%

Change from all-time low

284.4%

Change from open

0.47%

Day's gap

0.37%

Dollar volume

$7.3M

High price

$20.55

Low price

$19.18

Monthly RSI

45.28

Open price

$19.18

Position in 52-week range

6.57%

Previous close

$19.11

Price vs 150-day SMA

-27.61%

Price vs 20-day SMA

-13.51%

Price vs 200-day SMA

-23.34%

Price vs 50-day SMA

-34.53%

Relative volume

1.04

Return from IPO open

-95.9%

RSI

36.03

Sharpe ratio

0.94

Sharpe ratio (3Y)

0.65

Sharpe ratio (5Y)

0.18

Sortino ratio

2.93

Sortino ratio (3Y)

1.51

Sortino ratio (5Y)

0.44

Volume

378K

Weekly RSI

43.56

YTD price change

80.13%

YTD total return

80.13%

Metric	Value
Float	18.5M
Float percentage	71.64%
Shares change (QoQ)	335.75%
Shares change (YoY)	88.34%
Shares held by insiders	4.27%
Shares held by institutions	41.97%
Shares outstanding	25.8M
Short % of float	11.17%
Short % of shares	8%
Short ratio	4.8 days

Metric

Value

Float

18.5M

Float percentage

71.64%

Shares change (QoQ)

335.75%

Shares change (YoY)

88.34%

Shares held by insiders

4.27%

Shares held by institutions

41.97%

Shares outstanding

25.8M

Short % of float

11.17%

Short % of shares

Short ratio

4.8 days

Faeth Therapeutics, Inc. (FTH)

Price

Financial snapshot

Fair-value bridge

Latest news · FTH

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FTH indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on FTH

Frequently asked questions